Hao Guo

Title: Hao Guo: Innovator in Hematopoietic Treatments

Introduction

Hao Guo is a prominent inventor based in Hillsborough, NC (US). He has made significant contributions to the field of medical treatments, particularly in mitigating the side effects of chemotherapy and radiotherapy. His innovative approaches focus on enhancing patient recovery and improving overall health outcomes.

Latest Patents

Hao Guo holds a patent for "Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growth." This patent outlines methods for preventing and mitigating side effects from chemotherapy and radiotherapy by administering a therapeutically effective amount of a toll-like receptor 2/6 (TLR 2/6) ligand, specifically fibroblast-stimulating lipopeptide 1 (FSL-1). The patent also includes methods for treating gastrointestinal disorders and increasing granulocyte colony-stimulating factor (G-CSF) production in subjects undergoing medical treatments.

Career Highlights

Hao Guo is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve the quality of life for patients undergoing challenging medical treatments.

Collaborations

Hao Guo has collaborated with notable colleagues, including Jenny P-y Ting and Willie June Brickey. These partnerships have contributed to the development of his innovative treatments and have enhanced the impact of his research.

Conclusion

Hao Guo is a dedicated inventor whose work in hematopoietic treatments is paving the way for improved patient care. His innovative methods and collaborations highlight the importance of research in advancing medical science.